Alfa Chemistry Launches Donepezil for Alzheimer’s Disease Research
Alfa Chemistry, a long-term partner for many pharmaceutical companies, universities, and research institutions, recently announced to offer donepezil, a synthetic active pharmaceutical ingredient (API) that can be used in pharmaceutical preparation for the treatment of Alzheimer’s disease.
API refers to the biologically active component of a drug product. In recent decades, the great importance of APIs has been increasingly emphasized within the pharmaceutical industry, and vast research has been carried out from every possible angle, trying to maximize the number of effective formulations.
“The drug manufacturing sector has expanded dramatically over the past years, hence, the demand for APIs increases accordingly. As a chemical supplier trusted by a large number of customers, we’ve made the decision to provide a series of high-quality synthetic APIs at the most reasonable prices,” said the Marketing Chief of Alfa Chemistry. “Donepezil is the first API we launched. After almost half a year, its sales volume is quite eye-catching. We are very glad that this chemical has been well-received by the market and will continue to step up our efforts in bringing more APIs to both the research community and industry.”
Alzheimer’s disease (AD), the most common type of dementia, is a neurodegenerative disease featuring continuous decline in thinking, behavioral and social skills. Though no curing medication for Alzheimer’s is available yet, various possible treatments, drug or non-drug, have been extensively explored in the hope of slowing down the disease progression or relieving related symptoms. Among them, donepezil is of great interest and has been approved in several countries for anti-dementia. Donepezil demonstrated significant therapeutic effects on the treatment of Alzheimer’s disease.
“With a strong technical platform and professional technicians, we can ensure the safety of API production in line with the quality standards and the continuous improvement of cGMP requirements,” the Marketing Chief further added.
Please visit https://www.alfa-api.com/products/donepezil.html to learn more.
About Alfa Chemistry
Having more than 20 years of experience in the API field, Alfa Chemistry is missioned to provide innovative small molecule APIs for global pharmaceutical companies. The company has served more than 20 countries or regions such as the United States, United Kingdom, Canada, Germany, France, South Korea, and Japan. With a balanced and expanding product portfolio and combined with expertise, the scientific team of Alfa Chemistry can provide attractive solutions for drug developers. As for now, Alfa Chemistry offers the following synthetic chemical APIs: Epalrestat, Edaravone, Donepezil, Dexmedetomidine Hydrochloride, Lenalidomide, Parecoxib Sodium, Rivaroxaban, Tofacitinib Citrate, and Tamoxifen Citrate.
516 734 6573
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Ireland Daily News journalist was involved in the writing and production of this article.